Autolus Therapeutics (Autolus Therapeutics) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Days Sales Outstanding?

Autolus Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $0.14 Mil. Autolus Therapeutics's Revenue for the three months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Autolus Therapeutics's Days Sales Outstanding or its related term are showing as below:

AUTL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.13 Med: 15.93 Max: 26.48
Current: 26.48

During the past 8 years, Autolus Therapeutics's highest Days Sales Outstanding was 26.48. The lowest was 7.13. And the median was 15.93.

AUTL's Days Sales Outstanding is ranked better than
88.08% of 889 companies
in the Biotechnology industry
Industry Median: 71.83 vs AUTL: 26.48

Autolus Therapeutics's Days Sales Outstanding declined from Dec. 2022 (26.35) to Dec. 2023 (0.00).

Autolus Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Autolus Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Days Sales Outstanding Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

7.13

24.72

Autolus Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															26.35	8.55	-	29.78	-

Competitive Comparison of Autolus Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Autolus Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autolus Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Autolus Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Autolus Therapeutics's Days Sales Outstanding falls into.

Autolus Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Autolus Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.121	+	0.109)	/	2 )	/	1.698	*	365
=	0.115					/	1.698	*	365
=	24.72

Autolus Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.165	+	0.109)	/	2 )	/	0	*	365 / 4
=	0.137					/	0	*	365 / 4
=	N/A

Autolus Therapeutics (NAS:AUTL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Autolus Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

6A3A:Germany

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.